The Business of Biotech - Interview with Jay Flatley, CEO of Illumina, Part Two - August 8, 2010 - Segment Three

The Business of Biotech - Interview with Jay Flatley, Chief Executive Officer, Illumina Inc.

Prior to his appointment in 1999 as president and chief executive officer of Illumina, Jay was the president and chief executive officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. As a co-founder and member of the board of directors for Molecular Dynamics he led the Company to its initial public offering in 1993. While there, he also helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer.

Prior to joining Molecular Dynamics, Jay was vice president of engineering and strategic planning for Plexus Computers, a manufacturer of high-performance Unix super-microcomputers. Before his career at Plexus, Jay was executive vice president for Manning Technologies and held various manufacturing positions while working for the Autolab division of Spectra Physics. Currently, he is a member of the board of directors for both Illumina and GenVault Corporation and is a member of the Keck Graduate Institute board of trustees.

Jay received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University.

2Minutes&More with Betsy Berkhemer and Renee Fraser airs every Sunday at 1pm on KFWB NEWS TALK 980. Tune in for a full hour of tips for business success.